4th International Meeting on Laminopathies

4th International Meeting on Laminopathies is organized by One Congress and will be held from May 09 - 12, 2023 at Hotel ILUNION Atrium, Madrid, Spain.,Description:,The 4th International Meeting on Laminopathies will bring together a wide range of experts in the field of these rare diseases caused by mutations in genes encoding proteins of the nuclear envelope. Laminopathies can affect single tissues (mainly striated muscle, adipose tissue and peripheral nerve) or multiple organs. Numerous mutations have been associated with laminopathies, but the mechanisms underlying disease initiation and progression remain poorly characterized. Accordingly, there is a lack of specific and effective treatments for laminopathies. The meeting will be open to researchers, physicians and patients from around the world with the main goal of synergistically exchange knowledge and ideas to better understand laminopathies and help develop new therapies. The meeting will include sessions focused on basic-molecular research, disease-modeling, as well as therapeutic and clinical aspects of laminopathies. Patients will be part of the meeting in a specific session co-organized with scientists. The number of participants (~200) and format of the event will promote the dialogue between all the main stakeholders involved in the study of laminopathies. In summary, the 4th International Meeting on Laminopathies will be a multidisciplinary scientific meeting focused on helping researchers and clinicians to find effective therapies and eventually the cure for laminopathies.,Topics:,1. Clinical aspects of laminopathies (natural history, care and treatments, registers, biobanking),• Progeroid syndromes,• Lipodystrophies,• Peripheral nerve disorders,• Skeletal/Cardiac striated muscle laminopathies,2. Biomarkers,• With prognostic value and to measure response to treatments,3. Mechanisms underlying laminopathies,• Transcriptional regulation, metabolism, differentiation processes, nuclear envelope signalling,4. Disease Models,• 3D cell models, microfluidic devices, flies, mice, pigs…,5. Therapies,• Drug-based and advanced therapies,6. Patient Advocacy Organizations (PAO) sessions,• To be defined by patients